Cancer - STAT

Health By Andrew Joseph

STAT+ Conversations: A philosopher’s perspective on facing brain cancer in the time of Covid-19

Biotech By Adam Feuerstein

Blueprint Medicines partners with Roche to develop and sell genetically targeted cancer drug

Pharma By Elizabeth Cooney

Sanofi and MD Anderson team up to accelerate cancer drug testing

Pharmalot By Ed Silverman

Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir

Biotech By Jonathan Saltzman — Boston Globe

Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO

Health By Alexander Spinelli

Proposed changes to lung cancer screening guidance could increase scans among Black patients, women

Biotech By Damian Garde

With a clinical hold, off-the-shelf CAR-T hits a new safety concern

Biotech By Adam Feuerstein

Immunomedics’ breast cancer drug delays tumor growth, prolongs survival in clinical trial

Health Tech By Rebecca Robbins

An experiment in end-of-life care: Tapping AI’s cold calculus to nudge the most human of conversations

Health By Theresa Gaffney

A new FDA tool aims to inform cancer care, but experts say it has a glaring gap

Biotech By Adam Feuerstein

The biotech scorecard for the third quarter: 14 stock-moving events to watch

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Listen: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus

Health By Meghana Keshavan

As wave of Covid-19 cases crashes, a surge in other health conditions looms

Biotech By Damian Garde

Webinar: Targeted cancer drugs: What’s on the market? What’s in the pipeline?

Biotech By Elizabeth Cooney

Engineering a better immunotherapy to outwit cancer — and launch a biotech

First Opinion By Robert W. Carlson

Treatment barriers create racial disparities in cancer care. They need to come down

Pharmalot By Ed Silverman

Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case

Health By Elizabeth Cooney

Ignoring cancer care now may trade one public health crisis — Covid-19 — for another, NCI chief warns

In the Lab By Elizabeth Cooney

New findings about little-studied cellular compartments could help make chemo more effective

Pharmalot By Ed Silverman

Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials

By Matthew Herper

Eli Lilly gets an edge against Pfizer in adjuvant breast cancer

Health By Elizabeth Cooney

‘We have a job to do’: Cancer patients and their doctors carry on with clinical trials during Covid-19

Health By Matthew Herper

FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer

Pharmalot By Ed Silverman

Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals

Biotech By Kate Sheridan

Most Read

Harry Reid and Alex Trebek tried Patrick Soon-Shiong’s experimental cancer therapy. Can their results be duplicated in a clinical trial?

New cancer diagnoses fell sharply as the coronavirus pandemic first hit

23andMe had devastating news about my health. I wish a person had delivered it

Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration

Cancer is ‘natural.’ The best treatments for it aren’t

Colorectal cancer screening: Science should trump convenience

The cancer stories no one wants to hear

A cancer patient reconsiders her end-of-life wishes, as Covid-19 brings mortality into sharper focus

All Coverage

STAT+ Conversations: A philosopher’s perspective on facing brain cancer in the time of Covid-19

Blueprint Medicines partners with Roche to develop and sell genetically targeted cancer drug

Sanofi and MD Anderson team up to accelerate cancer drug testing

Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir

Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO

Proposed changes to lung cancer screening guidance could increase scans among Black patients, women

With a clinical hold, off-the-shelf CAR-T hits a new safety concern

Immunomedics’ breast cancer drug delays tumor growth, prolongs survival in clinical trial

An experiment in end-of-life care: Tapping AI’s cold calculus to nudge the most human of conversations

A new FDA tool aims to inform cancer care, but experts say it has a glaring gap

The biotech scorecard for the third quarter: 14 stock-moving events to watch

Listen: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus

As wave of Covid-19 cases crashes, a surge in other health conditions looms

Webinar: Targeted cancer drugs: What’s on the market? What’s in the pipeline?

Engineering a better immunotherapy to outwit cancer — and launch a biotech

Treatment barriers create racial disparities in cancer care. They need to come down

Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case

Ignoring cancer care now may trade one public health crisis — Covid-19 — for another, NCI chief warns

New findings about little-studied cellular compartments could help make chemo more effective

Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials

Eli Lilly gets an edge against Pfizer in adjuvant breast cancer

‘We have a job to do’: Cancer patients and their doctors carry on with clinical trials during Covid-19

FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer

Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals

In a first for RNA-modifying drugs, AstraZeneca partners with startup Accent Therapeutics